Viking Therapeutics (VKTX) Non-Current Deffered Revenue (2015 - 2018)
Viking Therapeutics' (VKTX) quarterly Non-Current Deffered Revenue came in at $12000.0 in Q4 2018, up 98.22% quarter-over-quarter from $6054.0 in Q2 2017.
Powered by 
Analysis
Viking Therapeutics (VKTX) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
Viking Therapeutics has disclosed Non-Current Deffered Revenue across 4 years of filings, most recently posting $12000.0 for Q4 2018.
- In Q4 2018, Non-Current Deffered Revenue changed N/A year-over-year to $12000.0; the TTM figure through Dec 2018 stood at $12000.0 (changed N/A YoY), while the FY2018 annual figure was $12000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue came in at $12000.0 for Q4 2018 at Viking Therapeutics, up from $6054.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $31239.0 in Q4 2015 to a low of $6054.0 in Q2 2017.
- Average Non-Current Deffered Revenue over 4 years is $18706.3, with a median of $19149.0 recorded in 2015.
- Year-over-year, Non-Current Deffered Revenue climbed 6.93% in 2016 and tumbled 75.44% in 2017.
- Over 4 years, Non-Current Deffered Revenue stood at $31239.0 in 2015, then sank by 47.8% to $16307.0 in 2016, then tumbled by 62.87% to $6054.0 in 2017, then soared by 98.22% to $12000.0 in 2018.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $12000.0 in Q4 2018, $6054.0 in Q2 2017, and $10862.0 in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 12,000.00 |
| Jun 30, 2017 | 6,054.00 |
| Mar 31, 2017 | 10,862.00 |
| Dec 31, 2016 | 16,307.00 |
| Sep 30, 2016 | 20,476.00 |
| Jun 30, 2016 | 24,646.00 |
| Mar 31, 2016 | 27,624.00 |
| Dec 31, 2015 | 31,239.00 |
| Sep 30, 2015 | 19,149.00 |
API Access
Viking Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();